PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
20-Oct-2022 Committed to staying ahead with pioneering glass packaging solutions that answer the changing needs of the pharmaceutical industry, SGD Pharma is set to showcase its latest innovations at CPhI worldwide 2022 SGD Pharma
20-Oct-2022 Invitation: Straumann Group 2022 third-quarter financial results webcast Straumann Holding AG
20-Oct-2022 Douglas GmbH: Sander van der Laan appointed as new DOUGLAS CEO – Tina Müller joins the Supervisory Board Douglas GmbH
20-Oct-2022 Kancera reports promising preclinical results from studies of its Fractalkine axis blocking drug candidates in B-cell lymphoma Kancera
20-Oct-2022 Chiesi and Aptar partner to bring to market Disease Management Platform for patients with asthma and COPD Chiesi
20-Oct-2022 BD to Showcase its Commitment to Drug Delivery and Packaging Innovation at CPhI Worldwide 2022 Conference BD (Becton, Dickinson and Company)
20-Oct-2022 STORM Therapeutics to present new data on its lead program STC-15 at the 34th EORTC-NCI-AACR Symposium and the 37th SITC Meeting STORM Therapeutics
20-Oct-2022 Beckman Coulter Life Sciences Proudly Presenting at American Society of Human Genetics Annual Meeting Beckman Coulter Life Sciences
20-Oct-2022 BD to Showcase its Commitment to Drug Delivery and Packaging Innovation at CPhI Worldwide 2022 Conference B3C newswire
20-Oct-2022 First successful year on the market for Marinomed’s Solv4U technology partnerships Marinomed Biotech AG
20-Oct-2022 After the first nine months, the Zur Rose Group is at the upper end of targets for revenue and EBITDA for 2022 Zur Rose Group AG
20-Oct-2022 Cosmo announces FDA grants orphan-drug designation of rifamycin for treatment of pouchitis Cosmo Pharmaceuticals N.V.
19-Oct-2022 AEVIS VICTORIA SA – AEVS.SW – Repayment of the CHF 145 million bond issued on 17 October 2016 AEVIS VICTORIA SA
19-Oct-2022 Jazz Pharmaceuticals And Zymeworks Announce Exclusive License Agreement To Develop And Commercialize Zanidatamab, A HER2-Targeted Bispecific Antibody Jazz Pharmaceuticals
19-Oct-2022 90-DAY ANALYSIS SHOWS MODERNA’S OMICRON BA.1-TARGETING BIVALENT VACCINE, mRNA-1273.214, DEMONSTRATES SUPERIOR ANTIBODY RESPONSE AS FOURTH BOOSTER COMPARED TO SPIKEVAX PROTOTYPE BOOSTER Moderna, Inc.
19-Oct-2022 Tiziana Life Sciences Ltd Invites You to Join Us at The ThinkEquity Conference Tiziana Life Sciences Ltd
19-Oct-2022 Cannovum AG welcomes concrete steps towards legalization of cannabis Cannovum AG
19-Oct-2022 Rewind Therapeutics Appoints Irene Knuesel, PhD, as Chief Scientific Officer Rewind Therapeutics
19-Oct-2022 Apogenix’ Asunercept Demonstrates Efficacy in Phase II Trial for the Treatment of Hospitalized COVID-19 Patients Apogenix AG
19-Oct-2022 Low-cost Haemophilia A treatment deal unlocks world of opportunity for ProFactor Pharma ProFactor Pharma